InterVene

company

About

InterVene is an up and coming medical device start-up company reinventing the way physicians treat severe venous disease in the legs.

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
$15M
Industries
Health Care,Medical,Medical Device
Founded date
Jan 1, 2011
Number Of Employee
11 - 50
Operating Status
Active

InterVene is an up and coming medical device start-up company reinventing the way physicians treat severe venous disease in the legs. This technology represents the first-ever catheter-based, non-implantable approach, which allows physicians to create new vein valves for patients who are unable to efficiently pump blood out of their legs and back to their hearts. Millions of Americans currently suffer from painful venous stasis ulcers (VSU’s) and other costly and devastating symptoms, yet no therapy currently exists to solve one of the most prevalent underlying causes: deep vein valve failure. InterVene plans to change that.

The company's mission is to provide the first effective and widely utilized therapy for patients suffering from the painful and costly symptoms of Chronic Venous Insufficiency (CVI) due to deep vein reflux (DVR). It was founded in 2011 and is based in South San Francisco, CA, USA.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$20.90M
InterVene has raised a total of $20.90M in funding over 2 rounds. Their latest funding was raised on Jun 25, 2019 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 25, 2019 Series B $15M 1 Detail
Mar 23, 2015 Series A $5.90M 1 Boston Scientific Detail

Investors

Number of Lead Investors
Number of Investors
1
1
InterVene is funded by 1 investors. Boston Scientific are the most recent investors.
Investor Name Lead Investor Funding Round
Boston Scientific Series B